{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:34Z","timestamp":1791425974160,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.vaccine.2005.01.089","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T12:33:59Z","timestamp":1107261239000},"page":"3256-3263","source":"Crossref","is-referenced-by-count":178,"title":["Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events"],"prefix":"10.1016","volume":"23","author":[{"given":"Alena Y.","family":"Khromava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Barwick","family":"Eidex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leisa H.","family":"Weld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin S.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Cetron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.01.089_bib1","series-title":"Vaccines","first-page":"815","article-title":"Yellow fever","author":"Monath","year":"1999"},{"issue":"RR-17","key":"10.1016\/j.vaccine.2005.01.089_bib2","first-page":"1","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2005.01.089_bib3","series-title":"Health information for international travel 2003\u20132004","year":"2003"},{"key":"10.1016\/j.vaccine.2005.01.089_bib4","unstructured":"Department of Defense (DoD). Air Force Joint Instruction 48-110. Army Regulation 40-562. Bumedinst 6230.15, CG Comdtinst M6230.4E. Immunizations and chemoprophylaxis. Washington, DC; 1995. http:\/\/www.e-publishing.af.mil\/pubfiles\/af\/48\/afji48-110\/afji48-110.pdf."},{"key":"10.1016\/j.vaccine.2005.01.089_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and Multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.01.089_bib6","first-page":"989","article-title":"Adverse events associated with 17-D-derived yellow fever vaccination\u2014United States, 2001\u20132002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2005.01.089_bib7","series-title":"Emerging infections","first-page":"25","article-title":"Yellow fever vaccine-associated disease","author":"Barwick","year":"2004"},{"key":"10.1016\/j.vaccine.2005.01.089_bib8","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(01)06914-8","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Adhiyaman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.01.089_bib9","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(01)06916-1","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Troillet","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.01.089_bib10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(01)06917-3","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Werfel","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.01.089_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.01.089_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2005.01.089_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2005.01.089_bib14","first-page":"244","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2005.01.089_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The Vaccine Adverse Event Reporting System (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.01.089_bib16","first-page":"52252","article-title":"21 Code of Federal Regulations (CFR) Part 600.80. Postmarketing reporting of adverse experiencies","volume":"62","year":"1997","journal-title":"Fed Reg"},{"issue":"4","key":"10.1016\/j.vaccine.2005.01.089_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2005.01.089_bib18","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX\u00ae","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"issue":"RR-12","key":"10.1016\/j.vaccine.2005.01.089_bib19","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 1999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2005.01.089_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1708-8305.1999.tb00839.x","article-title":"GeoSentinel: the global emerging infections sentinel network of the international society of travel medicine","volume":"6","author":"Freedman","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2005.01.089_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/421945","article-title":"Typhoid fever in travelers: who should be targeted for prevention?","volume":"39","author":"Steinberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.01.089_bib22","series-title":"Epi Info version 6: a word processing, database and statistics program for epidemiology on microcomputers","author":"Dean","year":"1994"},{"key":"10.1016\/j.vaccine.2005.01.089_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4269\/ajtmh.1929.s1-9.233","article-title":"Observations on the age and sex incidence of deaths and recoveries in the yellow fever epidemic in the department of Lambayeque, Peru, in 1921","volume":"9","author":"Hanson","year":"1929","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2005.01.089_bib24","unstructured":"Memorandum: Policy for reporting adverse events associated with the anthrax vaccine. Assistant Secretary of Defense; 1999."},{"key":"10.1016\/j.vaccine.2005.01.089_bib25","unstructured":"Zhou W, Pool V, Iskander JK, et al., Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS), United States 1991\u20132001. MMWR Surveill Summ 2003;52(SS-1):1\u201324 [erratum appears in MMWR Morb Mortal Wkly Rep 2003; 52:113]."},{"key":"10.1016\/j.vaccine.2005.01.089_bib26","unstructured":"Yellow Fever Vaccine YF-VAX\u00ae [Package insert]. AHFS Category 80:12. Swiftwater, PA: Aventis Pasteur Inc., 2003. http:\/\/www.vaccineshoppe.com\/US_PDF\/YFVAX_4291-4292_5_03.pdf."},{"key":"10.1016\/j.vaccine.2005.01.089_bib27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0140-6736(03)13075-9","article-title":"Preparing the traveller","volume":"361","author":"Spira","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.01.089_bib28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T01:20:29Z","timestamp":1548811229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":28,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0264410X05001283"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}